1. Home
  2. GKOS vs WSC Comparison

GKOS vs WSC Comparison

Compare GKOS & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • WSC
  • Stock Information
  • Founded
  • GKOS 1998
  • WSC 1944
  • Country
  • GKOS United States
  • WSC United States
  • Employees
  • GKOS N/A
  • WSC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • WSC Misc Corporate Leasing Services
  • Sector
  • GKOS Health Care
  • WSC Industrials
  • Exchange
  • GKOS Nasdaq
  • WSC Nasdaq
  • Market Cap
  • GKOS 5.4B
  • WSC 5.3B
  • IPO Year
  • GKOS 2015
  • WSC N/A
  • Fundamental
  • Price
  • GKOS $82.38
  • WSC $23.22
  • Analyst Decision
  • GKOS Strong Buy
  • WSC Buy
  • Analyst Count
  • GKOS 12
  • WSC 7
  • Target Price
  • GKOS $128.58
  • WSC $36.00
  • AVG Volume (30 Days)
  • GKOS 698.2K
  • WSC 2.0M
  • Earning Date
  • GKOS 11-03-2025
  • WSC 10-29-2025
  • Dividend Yield
  • GKOS N/A
  • WSC 1.21%
  • EPS Growth
  • GKOS N/A
  • WSC N/A
  • EPS
  • GKOS N/A
  • WSC 0.59
  • Revenue
  • GKOS $432,953,000.00
  • WSC $2,352,581,000.00
  • Revenue This Year
  • GKOS $28.79
  • WSC N/A
  • Revenue Next Year
  • GKOS $25.65
  • WSC $3.15
  • P/E Ratio
  • GKOS N/A
  • WSC $39.48
  • Revenue Growth
  • GKOS 26.70
  • WSC N/A
  • 52 Week Low
  • GKOS $77.10
  • WSC $21.91
  • 52 Week High
  • GKOS $163.71
  • WSC $42.15
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 35.40
  • WSC 40.06
  • Support Level
  • GKOS $80.52
  • WSC $22.79
  • Resistance Level
  • GKOS $95.32
  • WSC $23.73
  • Average True Range (ATR)
  • GKOS 2.82
  • WSC 0.68
  • MACD
  • GKOS -1.23
  • WSC 0.09
  • Stochastic Oscillator
  • GKOS 11.29
  • WSC 28.46

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.

Share on Social Networks: